#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraneoplastic neurological syndrome Urea cycle disorder Epileptic encephalopathy Acute promyelocytic leukaemia Gastrointestinal neuroendocrine tumour Familial haemophagocytic lymphohistiocytosis Chondrosarcoma metastatic Superficial vein thrombosis Chronic hepatitis B Acquired haemophilia Chorioretinitis Mucopolysaccharidosis II Neurodermatitis Marginal zone lymphoma recurrent Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Crigler-Najjar syndrome – Treatment Hypereosinophilic syndrome Alport’s syndrome Isodicentric chromosome 15 syndrome – Diagnostics Primary biliary cholangitis Pleomorphic leiomyosarcoma Mantle cell lymphoma stage II – Life with Disease VEXAS syndrome – Diagnostics Piriformis syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zanidatamab Tapderimotide Glimepiride POLYSORBATE 80 VHB937 Ramipril Pilocarpine Hydrochloride Rintatolimod Sodium Laurilsulfate Rp-1664 Sulfate S-241656 Vosilasarm Vidutolimod N-Acetylhistidine Ebastine Toripalimab Tub-040 Mycophenolate Sodium Gsk4527226 [18F]Mc225 More therapies…

    Learn about Your Condition

    Metastasis Gout Rectal cancer Procedural pain Tympanic membrane perforation Colon cancer stage II Acute lymphocytic leukaemia Clinically isolated syndrome Thyroid disorder Endocrine disorder Wheezing Ventricular tachycardia Astrocytoma malignant KBG syndrome Triple negative breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Frisius

Frisius

Henri Dunantweg 2, Heerenveen, 8934 AD, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on HPV Vaccine for Women with Vulvar HSIL: Evaluating the Effectiveness of Nonavalent HPV Vaccine in Preventing Recurrence of Vulvar High-Grade Lesions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the vulva
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    The Netherlands

  • Study on Patiromer for Improving RAAS Treatment in Patients with Chronic Kidney Disease Stages 3b/4

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Hydrochlorothiazide
    • Irbesartan
    The Netherlands

  • Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Belgium Germany The Netherlands Spain

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    • Acute myocardial infarction
    Investigated Drugs:
    • Noradrenaline Tartrate
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    The Netherlands

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Erythromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prolymphocytic leukaemia
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Abemaciclib
    • Alectinib
    • Alpelisib
    The Netherlands

  • Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer recurrent
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Belgium The Netherlands Norway Portugal Sweden

  • Dose-Reduced Oxaliplatin and Drug Combination Study for Older Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    The Netherlands
Previous Page
1 2 3 4 5 6 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!